Aragon, F., Carino, S., Perdigon, G. and De Moreno de LeBlanc, A., 2014. The administration of milk fermented by the probiotic Lactobacillus casei CRL 431 exerts an immunomodulatory effect against a breast tumor in a mouse model. Immunobiology 219: 457-464.

'The administration of milk fermented by the probiotic Lactobacillus casei CRL 431 exerts an immunomodulatory effect against a breast tumor in a mouse model ' () 219 Immunobiology : 457 -464.

The administration of milk fermented by the probiotic Lactobacillus casei CRL 431 exerts an immunomodulatory effect against a breast tumor in a mouse modelImmunobiology219457464)| false
• Search Google Scholar

Aragon, F., Carino, S., Perdigon, G. and De Moreno de LeBlanc, A., 2015. Inhibition of growth and metastasis of breast cancer in mice by milk fermented with Lactobacillus casei CRL 431. Journal of Immunotherapy 38: 185-196.

'Inhibition of growth and metastasis of breast cancer in mice by milk fermented with Lactobacillus casei CRL 431 ' () 38 Journal of Immunotherapy : 185 -196.

Inhibition of growth and metastasis of breast cancer in mice by milk fermented with Lactobacillus casei CRL 431Journal of Immunotherapy38185196)| false
• Search Google Scholar

Bertazza, L. and Mocellin, S., 2010. The dual role of tumor necrosis factor (TNF) in cancer biology. Current Medicinal Chemistry 17: 3337-3352.

'The dual role of tumor necrosis factor (TNF) in cancer biology ' () 17 Current Medicinal Chemistry : 3337 -3352.

The dual role of tumor necrosis factor (TNF) in cancer biologyCurrent Medicinal Chemistry1733373352)| false
• Search Google Scholar

Braumüller, H., Wieder, T., Brenner, E., Aβmann, S., Hahn, M., Alkhaled, M., Schilbach, K., Essmann, F., Kneilling, M., Griessinger, C., Ranta, F., Ullrich, S., Mocikat, R., Braungart, K., Mehra, T., Fehrenbacher, B., Berdel, J., Niessner, H., Meier, F., Van den Broek, M., Häring, H.-U., Handgretinger, R., Quintanilla-Martinez, L., Fend, F., Pesic, M., Bauer, J., Zender, L., Schaller, M., Schulze-Osthoff, K. and Röcken, M., 2013. T-helper-1-cell cytokines drive cancer into senescence. Nature 494: 361.

'T-helper-1-cell cytokines drive cancer into senescence ' () 494 Nature : 361.

T-helper-1-cell cytokines drive cancer into senescenceNature494361)| false
• Search Google Scholar

Chen, D.S. and Mellman, I., 2013. Oncology meets immunology: the cancer-immunity cycle. Immunity 39: 1-10.

'Oncology meets immunology: the cancer-immunity cycle ' () 39 Immunity : 1 -10.

Oncology meets immunology: the cancer-immunity cycleImmunity39110)| false
• Search Google Scholar

Chen, L., Huang, T.G., Meseck, M., Mandeli, J., Fallon, J. and Woo, S.L., 2007. Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation. Molecular Therapy 15: 2194-2202.

'Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation ' () 15 Molecular Therapy : 2194 -2202.

Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulationMolecular Therapy1521942202)| false
• Search Google Scholar

Dethlefsen, C., Hojfeldt, G. and Hojman, P., 2013. The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Research and Treatment 138: 657-664.

'The role of intratumoral and systemic IL-6 in breast cancer ' () 138 Breast Cancer Research and Treatment : 657 -664.

The role of intratumoral and systemic IL-6 in breast cancerBreast Cancer Research and Treatment138657664)| false
• Search Google Scholar

Dumeaux, V., Fjukstad, B., Fjosne, H.E., Frantzen, J.O., Holmen, M.M., Rodegerdts, E., Schlichting, E., Borresen-Dale, A.L., Bongo, L.A., Lund, E. and Hallett, M., 2017. Interactions between the tumor and the blood systemic response of breast cancer patients. PLoS Computational Biology 13: e1005680.

'Interactions between the tumor and the blood systemic response of breast cancer patients ' () 13 PLoS Computational Biology : e1005680.

Interactions between the tumor and the blood systemic response of breast cancer patientsPLoS Computational Biology13e1005680)| false
• Search Google Scholar

Dunn, G.P., Ikeda, H., Bruce, A.T., Koebel, C., Uppaluri, R., Bui, J., Chan, R., Diamond, M., White, J.M., Sheehan, K.C. and Schreiber, R.D., 2005. Interferon-gamma and cancer immunoediting. Immunologic Research 32: 231-245.

'Interferon-gamma and cancer immunoediting ' () 32 Immunologic Research : 231 -245.

Interferon-gamma and cancer immunoeditingImmunologic Research32231245)| false
• Search Google Scholar

Faghih, Z., Erfani, N., Haghshenas, M.R., Safaei, A., Talei, A.R. and Ghaderi, A., 2014. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes. Immunology Letters 158: 57-65.

'Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes ' () 158 Immunology Letters : 57 -65.

Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodesImmunology Letters1585765)| false
• Search Google Scholar

Hamidullah Changkija, B. and Konwar, R., 2012. Role of interleukin-10 in breast cancer. Breast Cancer Research and Treatment 133: 11-21.

'Role of interleukin-10 in breast cancer ' () 133 Breast Cancer Research and Treatment : 11 -21.

Role of interleukin-10 in breast cancerBreast Cancer Research and Treatment1331121)| false
• Search Google Scholar

Huang, Y., Ma, C., Zhang, Q., Ye, J., Wang, F., Zhang, Y., Hunborg, P., Varvares, M.A., Hoft, D.F., Hsueh, E.C. and Peng, G., 2015. CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome. Oncotarget 6: 17462-17478.

'CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome ' () 6 Oncotarget : 17462 -17478.

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcomeOncotarget61746217478)| false
• Search Google Scholar

Kano, A., 2015. Tumor cell secretion of soluble factor(s) for specific immunosuppression. Scientific Reports 5: 8913.

'Tumor cell secretion of soluble factor(s) for specific immunosuppression ' () 5 Scientific Reports : 8913.

Tumor cell secretion of soluble factor(s) for specific immunosuppressionScientific Reports58913)| false
• Search Google Scholar

Lippitz, B.E., 2013. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncology 14: e218-228.

'Cytokine patterns in patients with cancer: a systematic review ' () 14 Lancet Oncology : e218 -228.

Cytokine patterns in patients with cancer: a systematic reviewLancet Oncology14e218228)| false
• Search Google Scholar

Masuda, J., Takayama, E., Strober, W., Satoh, A., Morimoto, Y., Honjo, Y., Ichinohe, T., Tokuno, S.I., Ishizuka, T., Nakata, T., Mizutani, A., Umemura, N., Kitani, A., Fuss, I.J., Shigehiro, T., Kawaki, H., Mizuno-Kamiya, M., Kondoh, N. and Seno, M., 2017. Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities. Oncology Reports 38: 449-455.

'Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities ' () 38 Oncology Reports : 449 -455.

Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunitiesOncology Reports38449455)| false
• Search Google Scholar

Mendez Utz, V.E., Perdign, G. and De Moreno de LeBlanc, A., 2019. Oral administration of milk fermented by Lactobacillus casei CRL431 was able to decrease metastasis from breast cancer in a murine model by modulating immune response locally in the lungs. Journal of Functional Foods 54: 263-270.

'Oral administration of milk fermented by Lactobacillus casei CRL431 was able to decrease metastasis from breast cancer in a murine model by modulating immune response locally in the lungs ' () 54 Journal of Functional Foods : 263 -270.

Oral administration of milk fermented by Lactobacillus casei CRL431 was able to decrease metastasis from breast cancer in a murine model by modulating immune response locally in the lungsJournal of Functional Foods54263270)| false
• Search Google Scholar

Merendino, R.A., Arena, A., Capozza, A.B., Chillemi, S. and Mesiti, M., 1996. Serum levels of interleukin-10 in patients affected by breast cancer. Immunology Letters 53: 59-60.

'Serum levels of interleukin-10 in patients affected by breast cancer ' () 53 Immunology Letters : 59 -60.

Serum levels of interleukin-10 in patients affected by breast cancerImmunology Letters535960)| false
• Search Google Scholar

Nakasone, E.S., Hurvitz, S.A. and McCann, K.E., 2018. Harnessing the immune system in the battle against breast cancer. Drugs Context 7: 212520.

'Harnessing the immune system in the battle against breast cancer ' () 7 Drugs Context : 212520.

Harnessing the immune system in the battle against breast cancerDrugs Context7212520)| false
• Search Google Scholar

Nocera, N.F., Lee, M.C., De la Cruz, L.M., Rosemblit, C. and Czerniecki, B.J., 2016. Restoring lost anti-HER-2 Th1 immunity in breast cancer: a crucial role for Th1 cytokines in therapy and prevention. Frontiers in Pharmacology 7: 356.

'Restoring lost anti-HER-2 Th1 immunity in breast cancer: a crucial role for Th1 cytokines in therapy and prevention ' () 7 Frontiers in Pharmacology : 356.

Restoring lost anti-HER-2 Th1 immunity in breast cancer: a crucial role for Th1 cytokines in therapy and preventionFrontiers in Pharmacology7356)| false
• Search Google Scholar

Pulaski Beth, A. and Ostrand-Rosenberg, S., 2001. Mouse 4T1 breast tumor model. Current Protocols in Immunology 39: 20.22.21-20.22.16.

'Mouse 4T1 breast tumor model ' () 39 Current Protocols in Immunology : 20.22.21 -20.22.16.

Mouse 4T1 breast tumor modelCurrent Protocols in Immunology3920.22.2120.22.16)| false
• Search Google Scholar

Schreiber, R.D., Old, L.J. and Smyth, M.J., 2011. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331: 1565-1570.

'Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion ' () 331 Science : 1565 -1570.

Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotionScience33115651570)| false
• Search Google Scholar

Shankaran, V., Ikeda, H., Bruce, A.T., White, J.M., Swanson, P.E., Old, L.J. and Schreiber, R.D., 2001. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410: 1107-1111.

'IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity ' () 410 Nature : 1107 -1111.

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicityNature41011071111)| false
• Search Google Scholar

Shrihari, T.G., 2017. Dual role of inflammatory mediators in cancer. Ecancermedicalscience 11: 721.

'Dual role of inflammatory mediators in cancer ' () 11 Ecancermedicalscience : 721.

Dual role of inflammatory mediators in cancerEcancermedicalscience11721)| false
• Search Google Scholar

Takeda, K., Nakayama, M., Hayakawa, Y., Kojima, Y., Ikeda, H., Imai, N., Ogasawara, K., Okumura, K., Thomas, D.M. and Smyth, M.J., 2017. IFN-gamma is required for cytotoxic T cell-dependent cancer genome immunoediting. Nature Communications 8: 14607.

'IFN-gamma is required for cytotoxic T cell-dependent cancer genome immunoediting ' () 8 Nature Communications : 14607.

IFN-gamma is required for cytotoxic T cell-dependent cancer genome immunoeditingNature Communications814607)| false
• Search Google Scholar

Vesely, M.D. and Schreiber, R.D., 2013. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy. Annals of the New York Academy of Sciences 1284: 1-5.

'Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy ' () 1284 Annals of the New York Academy of Sciences : 1 -5.

Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapyAnnals of the New York Academy of Sciences128415)| false
• Search Google Scholar

Vinay, D.S., Ryan, E.P., Pawelec, G., Talib, W.H., Stagg, J., Elkord, E., Lichtor, T., Decker, W.K., Whelan, R.L., Kumara, H., Signori, E., Honoki, K., Georgakilas, A.G., Amin, A., Helferich, W.G., Boosani, C.S., Guha, G., Ciriolo, M.R., Chen, S., Mohammed, S.I., Azmi, A.S., Keith, W.N., Bilsland, A., Bhakta, D., Halicka, D., Fujii, H., Aquilano, K., Ashraf, S.S., Nowsheen, S., Yang, X., Choi, B.K. and Kwon, B.S., 2015. Immune evasion in cancer: mechanistic basis and therapeutic strategies. Seminars in Cancer Biology 35: S185-S198.

'Immune evasion in cancer: mechanistic basis and therapeutic strategies ' () 35 Seminars in Cancer Biology : S185 -S198.

Immune evasion in cancer: mechanistic basis and therapeutic strategiesSeminars in Cancer Biology35S185S198)| false
• Search Google Scholar

Welte, T. and Zhang, X.H., 2015. Interleukin-17 could promote breast cancer progression at several stages of the disease. Mediators of Inflammation 2015: 804347.

'Interleukin-17 could promote breast cancer progression at several stages of the disease ' () 2015 Mediators of Inflammation : 804347.

Interleukin-17 could promote breast cancer progression at several stages of the diseaseMediators of Inflammation2015804347)| false
• Search Google Scholar

Young, S.H., Antonini, J.M., Roberts, J.R., Erdely, A.D. and Zeidler-Erdely, P.C., 2008. Performance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent models. Journal of Immunological Methods 331: 59-68.

'Performance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent models ' () 331 Journal of Immunological Methods : 59 -68.

Performance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent modelsJournal of Immunological Methods3315968)| false
• Search Google Scholar

Zhou, L., Zhang, X., Li, H., Niu, C., Yu, D., Yang, G., Liang, X., Wen, X., Li, M. and Cui, J., 2018. Validating the pivotal role of the immune system in low-dose radiation-induced tumor inhibition in Lewis lung cancer-bearing mice. Cancer Medicine 7: 1338-1348.

'Validating the pivotal role of the immune system in low-dose radiation-induced tumor inhibition in Lewis lung cancer-bearing mice ' () 7 Cancer Medicine : 1338 -1348.

Validating the pivotal role of the immune system in low-dose radiation-induced tumor inhibition in Lewis lung cancer-bearing miceCancer Medicine713381348)| false
• Search Google Scholar